|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2011-8-25
|
|
pubmed:abstractText |
To investigate the levels of HBsAg in predicting the efficacy of peglated interferon-alpha 2a combined with adefovir dipivoxil (ADV), in HBeAg-positive chronic hepatitis B patients.
|
|
pubmed:language |
chi
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1003-9279
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
25
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
132-4
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:21863639-Adenine,
pubmed-meshheading:21863639-Adult,
pubmed-meshheading:21863639-Antiviral Agents,
pubmed-meshheading:21863639-Drug Therapy, Combination,
pubmed-meshheading:21863639-Female,
pubmed-meshheading:21863639-Hepatitis B, Chronic,
pubmed-meshheading:21863639-Hepatitis B Surface Antigens,
pubmed-meshheading:21863639-Hepatitis B e Antigens,
pubmed-meshheading:21863639-Hepatitis B virus,
pubmed-meshheading:21863639-Humans,
pubmed-meshheading:21863639-Interferon-alpha,
pubmed-meshheading:21863639-Male,
pubmed-meshheading:21863639-Phosphonic Acids,
pubmed-meshheading:21863639-Recombinant Proteins,
pubmed-meshheading:21863639-Treatment Outcome
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
[The levels of HBsAg can predict the efficacy of peglated interferon-alpha 2a combined with adefovir dipivoxil, in HBeAg-positive chronic hepatitis B patients].
|
|
pubmed:affiliation |
Department of Infectious Disease, Third Affiliated Hospital of Sun-Yat-Sen University, Guangzhou 510630, China.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
English Abstract,
Research Support, Non-U.S. Gov't
|
